Ainos Tech Completes Series C+ Financing to Advance Digital Transformation in China's Eye Health and School Hygiene Sectors

VCBeat has learned that Beijing Ainuos Technology Co., Ltd. (“Ainuos Technology”) recently completed its C+ round of financing, with Yingchuan Capital and Huaxia Zhixun as the investors. The funds raised will be used for research into the application of artificial intelligence technologies in the fields of eye health and school health informatization.

Beijing Ainuos Technology Co., Ltd. was registered and established in Beijing in 2016, dedicated to the research and application of artificial intelligence technologies in the fields of eye health and school hygiene informatization. In 2019, it received investment from Donghua Software (002065), a listed company. The company is recognized as a National High-Tech Enterprise and a Zhongguancun High-Tech Enterprise. Ainuos Technology jointly established the “Peking University Health Science Center–Ainuos Artificial Intelligence Joint Laboratory” with Peking University Health Science Center and has obtained ISO 9001 certification. In 2020, the company delivered outstanding performance in epidemic prevention and control efforts, receiving a Letter of Commendation from the National Health Commission. In 2021, it provided comprehensive technical support for the “National Eye Health Survey” conducted by the National Technical Guidance Group for Blindness Prevention under the Department of Medical Administration of the National Health Commission. In 2022, it provided comprehensive technical support for the “National Survey on Hyperopia Reserve Status among Children and Adolescents” undertaken by the National Disease Control and Prevention Administration. In 2023, under the guidance of the China Association for Science and Technology, the “Beijing Ainuos Association for Science and Technology” was established.

Beijing Ainuos Technology Co., Ltd. has independently developed the “National Vision and Common Disease Monitoring and Early Warning System for Children and Adolescents” based on technologies such as the Internet of Things (IoT), artificial intelligence (AI), big data, and 5G. This system establishes a multi-level collaborative prevention, control, monitoring, and early warning framework for regulatory authorities, education bureaus/schools, healthcare institutions, and families/students. The technology has been designated as a “National Health Technology” by the National Health Commission. In collaboration with the Chinese Center for Disease Control and Prevention, the Beijing Center for Disease Control and Prevention, Beijing Tongren Hospital, and other entities, the company has participated in the formulation of multiple national standards. In 2020, it received the Excellence Award for “Social Impact of Innovative Applications in Smart Healthcare in China.”In 2023, Beijing Ainuos Technology Co., Ltd. launched the “eYenurse Smart Ophthalmology Cloud Platform,” which helps ophthalmic hospitals, optometry centers, and ophthalmology clinics achieve full-process digitalization and standardization across pre-diagnosis, during-diagnosis, and post-diagnosis stages. By leveraging AI-assisted diagnosis and treatment, remote consultations, and two-way referrals, the platform enhances the eye health service capabilities of primary healthcare institutions, facilitates the downward distribution of high-quality medical resources, enables precise patient care, and supports the development of China’s tiered diagnosis and treatment system.

Currently, the products and technologies of Ainuos Technology have been implemented in over 1,300 institutions across 31 provinces in China. They are widely applied in the following areas: the “Surveillance and Intervention for Common Student Diseases and Health Influencing Factors” conducted by Centers for Disease Control and Prevention at all levels; the “Eye Care and Vision Screening for Children Aged 0–6 Years” carried out by Maternal and Child Health Hospitals; the “Vision Monitoring Data Reporting for Primary and Secondary School Students” managed by Education Bureaus and schools; and the development of digital service capabilities for ophthalmic institutions across pre-diagnosis, intra-diagnosis, and post-diagnosis stages.The system has been applied for nearly seven years, completing eye health screenings for 13 million individuals and over 30 million visits, achieving zero errors in data reporting.

Beijing Ainuos Technology Co., Ltd.’s major clients include the Chinese Center for Disease Control and Prevention, Beijing Municipal Center for Disease Control and Prevention, Qinghai Provincial Center for Disease Control and Prevention, Peking University People’s Hospital, Beijing Tongren Hospital, Hunan Provincial Maternal and Child Health Care Hospital, Beijing Fengtai District Maternal and Child Health Care Hospital, Zaozhuang City Maternal and Child Health Care Hospital, Beijing Daxing District Education Commission, Kaifeng Municipal Education Bureau, Nanchang Municipal Education Bureau, Aier Eye Hospital Group, Huaxia Eye Hospital Group, and Purui Eye Hospital.

Donghua Software Corporation (Stock Code: 002065) IT Services II–IT Services III is a key software enterprise under the national planning layout, a key high-tech enterprise in the National Torch Program, and an extra-large enterprise in computer services and software. It is the first company in China to simultaneously hold qualifications for Level-1 System Integration, Class-A Confidentiality Qualification, and CMMI5. Its major investment projects include Aerospace Software (Stock Code: 688562), among others.

Beijing Yingchuan Investment Management Co., Ltd. specializes in investment management, project investment, and asset management. Its key investment projects include Zhongneng Jinshi Energy and Weiyi Health.

Beijing Huaxiazhixun Technology Co., Ltd. specializes in basic software, application software, computer systems, and data processing. Its major investment projects include Guorui Technology (stock code: 600562), Military Electronics II, Military Electronics III, etc.